• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4679279)   Today's Articles (302)
For: Wyndaele JJ. MODULATION OF NON-VOIDING ACTIVITY BY THE MUSCARINERGIC ANTAGONIST TOLTERODINE AND THE β3-ADRENOCEPTOR AGONIST MIRABEGRON IN CONSCIOUS RATS WITH PARTIAL OUTFLOW OBSTRUCTION. BJU Int 2012;110:E143. [DOI: 10.1111/j.1464-410x.2012.11259.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Number Cited by Other Article(s)
1
Shared Pathophysiology of Detrusor Overactivity and Detrusor Underactivity. CURRENT BLADDER DYSFUNCTION REPORTS 2018. [DOI: 10.1007/s11884-018-0490-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
2
Sacco E, Bientinesi R, Bassi P, Currò D. Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review. Int Urogynecol J 2016;27:1633-1644. [DOI: 10.1007/s00192-016-2977-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2015] [Accepted: 02/04/2016] [Indexed: 11/24/2022]
3
Kashyap M, Tyagi P. The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option. Expert Opin Drug Metab Toxicol 2013;9:617-27. [DOI: 10.1517/17425255.2013.786700] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA